Pfizer's 95% Efficacy Is Exciting, Says Ginkgo Bioworks CEO

Nov.20 -- Jason Kelly, chief executive officer and co-founder at Ginkgo Bioworks Inc., discusses news of a potential vaccine to prevent Covid-19 on "Bloomberg Technology."